Cefuroxime (2Nd Gen) Tablets/Capsules Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets/Capsules

Available Strengths: 250 mg, 500 mg

Reference Brands: Ceftin, Zinacef(US & EU)

Category: Antibiotics

Cefuroxime inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial lysis. It is effective against respiratory, urinary, skin, and soft tissue infections. Benefits include broad-spectrum activity, rapid bacterial eradication, and oral administration, making it a reliable choice for treating common bacterial infections when used appropriately. Cefuroxime (2nd Gen) Tablets/Capsules is available in Oral Tablets/Capsules and strengths such as 250 mg, 500 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Cefuroxime (2nd Gen) Tablets/Capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Cefuroxime (2nd Gen) Tablets/Capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Cefuroxime (2nd generation cephalosporin) tablets and capsules are approved in both the EU and US for treating respiratory, urinary, and skin bacterial infections. In the EU, brands like Ceftin and Zinacef are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans. For regulatory support, compliance, and registration, visit PharmaTradz. We support seamless market access for cefuroxime, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.